Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Docosanoids [FA04]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA04010498 ent-13-epi-13-J4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010499 14-epi-14-J4-NeuroP (Z)-6-((1S,5S)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010500 ent-7-epi-14-J4-NeuroP (Z)-6-((1S,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010501 7,14-diepi-14-J4-NeuroP (Z)-6-((1R,5S)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010502 ent-14-J4-NeuroP (Z)-6-((1R,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010503 14-J4-NeuroP (Z)-6-((1S,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010504 ent-7,14-diepi-14-J4-NeuroP (Z)-6-((1S,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010505 7-epi-14-J4-NeuroP (Z)-6-((1R,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010506 ent-14-epi-14-J4-NeuroP (Z)-6-((1R,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010507 17-epi-17-J4-NeuroP (4Z,7Z)-9-((1S,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010508 ent-10-epi-17-J4-NeuroP (4Z,7Z)-9-((1S,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010509 10,17-diepi-17-J4-NeuroP (4Z,7Z)-9-((1R,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010510 ent-17-J4-NeuroP (4Z,7Z)-9-((1R,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010511 17-J4-NeuroP (4Z,7Z)-9-((1S,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010512 ent-10,17-diepi-17-J4-NeuroP (4Z,7Z)-9-((1S,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010513 10-epi-17-J4-NeuroP (4Z,7Z)-9-((1R,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010514 ent-17-epi-17-J4-NeuroP (4Z,7Z)-9-((1R,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010515 20-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010516 ent-13-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010517 13,20-diepi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010518 ent-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010519 20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010520 ent-13,20-diepi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010521 13-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010522 ent-20-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04050003 (7S)-Maresin 1 7S,14S-dihydroxy-4Z,8E,10E,12E,16Z,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230060
LMFA04000091 Resolvin T1 7,13,20-Trihydroxy-8E,10Z,14E,16Z,18E-docosapentaenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04000092 Resolvin T2 7,8,13-Trihydroxy-9E,11E,14E,16Z,19Z-docosapentaenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04000093 Resolvin T3 7,12,13-Trihydroxy-8Z,10E,14E,16Z,19Z-docosapentaenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04000094 Resolvin T4 7,13-Dihydroxy-8E,10Z,14E,16Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245710
LMFA04050004 Maresin 2 13R,14S-dihydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230060
LMFA04030013 Resolvin D6i 4R,17R-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230060
LMFA04000095 Cymatherol C 9-[(1R,2S,3S,5S)-3-[(1S,2R)-2-[(1R)-1-Hydroxypropyl]cyclopropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]nona-5Z,8Z-dienoic acid FA 20:5;O2 C20H30O4 334.214410
LMFA04050005 MCTR1 13R-(S-glutathionyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid C32H47N3O9S 649.303304
LMFA04050006 MCTR2 13R-(S-cysteinylglycinyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid C27H40N2O6S 520.260710
LMFA04050007 MCTR3 13R-(S-cysteinyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid C25H37NO5S 463.239246
LMFA04040004 PCTR1 16R-(S-glutathionyl)-17S-hydroxy-4Z,7Z,10Z,12E,14E,19Z-docosahexaenoic acid C32H47N3O9S 649.303304
LMFA04040005 PCTR2 16R-(S-cysteinylglycinyl)-17S-hydroxy-4Z,7Z,10Z,12E,14E,19Z-docosahexaenoic acid C27H40N2O6S 520.260710
LMFA04040006 PCTR3 16R-(S-cysteinyl)-17S-hydroxy-4Z,7Z,10Z,12E,14E,19Z-docosahexaenoic acid C25H37NO5S 463.239246
LMFA04030014 RCTR1 8-(S-glutathionyl)-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid C32H47N3O10S 665.298219
LMFA04030015 RCTR2 8-(S-cysteinylglycinyl)-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid C27H40N2O7S 536.255625
LMFA04030016 RCTR3 8-(S-cysteinyl)-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid C25H37NO6S 479.234161
LMFA04000096 Protectin D1n-3 DPA 10R,17S-dihydroxy-7Z,11E,13E,15Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245710
LMFA04000097 Protectin D2n-3 DPA 16R,17S-dihydroxy-7Z,10Z,12E,14E,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245710
LMFA04000098 Mar1n-3 DPA 7R,14S-dihydroxy-8E,10E,12Z,16Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245710
LMFA04000099 Leiopathic acid 10R-hydroxy-7Z,11E,13Z,16Z,19Z-docosapentaenoic acid FA 22:5;O C22H34O3 346.250795
LMFA04000100 Aplidic acid A (5E,7E)-8-[(3aR,4R,5R,7aS)-4-[(1E,3E)-5-methoxy-5-oxopenta-1,3-dienyl]-2,3,3a,4,5,7a-hexahydro-1H-inden-5-yl]octa-5,7-dienoic acid FA 23:8;O2 C23H30O4 370.214410
LMFA04000101 (5E,7E)-8-[(3aR,4R,5R,7aS)-4-[(1Z,3E)-5-hydroxy-5-oxopenta-1,3-dienyl]-2,3,3a,4,5,7a-hexahydro-1H-inden-5-yl]octa-5,7-dienoic acid FA 22:8;O2 C22H28O4 356.198760
LMFA04000102 11,17-diHDoHE 11S,17S-dihydroxy-4Z,7Z,9E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230060
LMFA04000103 11,17-diHDoPE 11S,17S-dihydroxy-7Z,9E,13Z,15E,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245710